Navigation Links
Shiner Beers launches nationwide support of TGen diabetes studies

AUSTIN, Texas March 12, 2013 Shiner Beers, the popular Texas craft brew, will launch a nationwide campaign to support The Waylon Jennings Fund for Diabetes Research at the Translational Genomics Research Institute (TGen).

The Waylon Fund partnership between Shiner and TGen will kick off on Wednesday, March 13, at the Hotel San Jos in downtown Austin during the 2013 South by Southwest Conferences & Festivals.

The noon-8 p.m. event, themed after the legendary Armadillo World Headquarters music hall, features music by Asleep At The Wheel, Jimmie Dale Gilmore, and Shooter Jennings, the son of Waylon and a co-founder of The Waylon Fund at TGen. Waylon passed away in 2002 from complications of diabetes.

"When you consider all the connections between Waylon, his music, Shiner Beers and Texas music culture, partnering with TGen aligned perfectly with our community outreach efforts," said Charlie Paulette, Shiner's Chief Sales and Marketing Officer.

Waylon's widow, Jessi Colter, will toast the partnership. "We just have such a love for Waylon and what he was," Paulette said. "And the fact that his wife and son will be there will make this celebration extremely special."

Throughout the 1970s, Armadillo World Headquarters was a launching pad for Shiner's brews as well as Waylon' "Outlaw" brand of country music.

TGen's research into diabetes will allow physicians to more accurately predict who has the greatest risk of developing Type 2 diabetes and related complications, while also identifying targets for treatment of the disease.

Shiner plans to generate funds and awareness of diabetes which affects nearly 26 million Americans by sponsoring Waylon Birthday Bashes across the country this June. Already, 13 Waylon bashes are confirmed. Dozens more are expected.

Howard Young, a TGen Foundation Board Member and President of Atlanta-based General Wholesale Beer Company, which distributes Shiner in Georgia, first suggested the Shiner/TGen collaboration.

"As a cancer survivor, I can attest to the cutting-edge medical research performed by TGen, and as a distributor of Shiner, I have seen their great generosity in support of other medical research," Young said. "Teaming up Shiner and TGen's Waylon Fund is a perfect partnership of southwest musical culture and the advanced medical technology that has saved my life."

In February, Academy-Award-winning actor Jeff Bridges joined TGen's National Honorary Committee in support of The Waylon Fund, whose members also include country music stars Keith Urban, Kris Kristofferson, Jamey Johnson and Billy Ray Cyrus.

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Related biology news :

1. Wake Forest Innovations Launches New Dot-Com Companies Offering Industry and Business Easy Access to Broad Range of Scientific Services
2. Entomological Society of America launches science policy program
3. MSU launches groundbreaking drug trial in Africa
4. NTU launches new centre to develop new eye-deas for occular therapeutics
5. Elsevier launches new open access journal: Molecular Metabolism
6. Canada launches first gene therapy trial for Fabry disease
7. Elsevier launches new journal: Journal of Unconventional Oil and Gas Resources
8. F1000Research, the first Open Science publisher, launches following a successful beta testing phase
9. Wake Forest Baptist Medical Center Launches Wake Forest Innovations
10. Neurotechnology Launches SkyBiometry Spin-off Company to Deliver SaaS Biometric Identification and Feature Analysis
11. Elsevier launches new open access journal -- Case Studies in Engineering Failure Analysis
Post Your Comments:
(Date:9/3/2020)... ... 2020 , ... Litmus Health , the research-ready infrastructure ... the company’s security practices has been completed. The assessment deemed Litmus infrastructure to ... reviewed Litmus’ processes and systems, assessing them to see whether they adhere to ...
(Date:8/26/2020)... (PRWEB) , ... August 25, ... ... clinical-stage biotechnology company developing novel pharmaceuticals targeting mitochondria, in partnership with Essex ... enrolment in its pivotal U.S. Phase 3 VISTA-2 study of SkQ1 ophthalmic ...
(Date:8/26/2020)... ... ... Modality Solutions, a biopharmaceutical cold chain validation engineering firm, is pleased to ... most prestigious ranking of the nation’s fastest-growing private companies. Modality Solutions made the Inc. ... growth of 71 percent. , The Inc. 5000 list represents a unique look ...
Breaking Biology News(10 mins):
(Date:8/31/2020)... (PRWEB) , ... August 29, 2020 , ... ... new Animal Nutrition manufacturing capability in Wuxi, China. The new plant operation will ... quality standards and advanced technology. , “This facility will improve the flexibility ...
(Date:8/12/2020)... ... August 11, 2020 , ... The FSHD Society announced ... Dystrophy Clinical Trial Research Network (FSHD CTRN), with consideration of follow-on ... consortium of academic research centers in the United States and Europe with expertise ...
(Date:8/7/2020)... ... August 06, 2020 , ... VGXI, a ... has closed on the purchase of greenfield for a new, expanded manufacturing facility. ... over 21 acres in the initial acquisition, with an option to purchase an ...
(Date:7/31/2020)... ... 2020 , ... R3 Stem Cell International is now offering patients the opportunity ... cells total, patients may choose which extremities they would like treated. , Several studies ... Disord. 2016). At R3 International, umbilical cord tissue is obtained from a lab with ...
Breaking Biology Technology: